293 related articles for article (PubMed ID: 26847337)
1. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.
Dabestani S; Thorstenson A; Lindblad P; Harmenberg U; Ljungberg B; Lundstam S
World J Urol; 2016 Aug; 34(8):1081-6. PubMed ID: 26847337
[TBL] [Abstract][Full Text] [Related]
2. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
3. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.
Kuijpers YA; Meijer RP; Jonges GN; de Jong J; Bosch JL; Horenblas S; Bex A
World J Urol; 2016 Aug; 34(8):1073-9. PubMed ID: 27055532
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.
Steiner T; Kirchner H; Siebels M; Doehn C; Heynemann H; Varga Z; Rohde D; Schubert J; Jocham D; Stief C; Fornara P; Hofmann R; Loening S; Roigas J
J Cancer Res Clin Oncol; 2010 Jun; 136(6):905-10. PubMed ID: 20012752
[TBL] [Abstract][Full Text] [Related]
6. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
[TBL] [Abstract][Full Text] [Related]
7. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
[TBL] [Abstract][Full Text] [Related]
8. Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
Franzese C; Franceschini D; Di Brina L; DʼAgostino GR; Navarria P; Comito T; Mancosu P; Tomatis S; Scorsetti M
J Urol; 2019 Jan; 201(1):70-75. PubMed ID: 30577391
[TBL] [Abstract][Full Text] [Related]
9. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
[TBL] [Abstract][Full Text] [Related]
10. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients.
Lieder A; Guenzel T; Lebentrau S; Schneider C; Franzen A
Int Braz J Urol; 2017; 43(2):202-208. PubMed ID: 27649110
[TBL] [Abstract][Full Text] [Related]
12. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.
Saidi JA; Newhouse JH; Sawczuk IS
Urology; 1998 Dec; 52(6):1000-3. PubMed ID: 9836544
[TBL] [Abstract][Full Text] [Related]
13. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
14. Lung metastasectomy in patients with renal cell cancer (RCC). A 17-year experience in Parma Hospital.
Ferretti S; Fornia S; Ampollini L; Rusca M; Salsi P; Vaglio A; Cortellini P
Acta Biomed; 2007; 78(1):41-5. PubMed ID: 17687816
[TBL] [Abstract][Full Text] [Related]
15. Solitary, late metastatic recurrence of renal cell carcinoma: two extraordinary cases.
Featherstone JM; Bass P; Cumming J; Smart CJ
Int J Urol; 2006 Dec; 13(12):1525-7. PubMed ID: 17118029
[TBL] [Abstract][Full Text] [Related]
16. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.
Stewart-Merrill SB; Thompson RH; Boorjian SA; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Frank I
J Clin Oncol; 2015 Dec; 33(35):4151-7. PubMed ID: 26351352
[TBL] [Abstract][Full Text] [Related]
18. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
19. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
Levy DA; Slaton JW; Swanson DA; Dinney CP
J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
[TBL] [Abstract][Full Text] [Related]
20. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
